We previously have found that in a substantial number of AML cases, CD34+CD38- LSCs are characterized by the expression of C-type lectin-like molecule-1 (CLL-1) and aberrant expression of several lineage markers [18], [19]. This evidence concerns the gene CD38 and acute myeloid leukemia.